Background Organ transplant is the preferred treatment for end-stage organ disease, yet the
majority of patients with end-stage organ disease are never placed on the transplant waiting …

Transplantation remains the modality of choice for patients with end stage renal disease
(ESRD). However, while there has been a steady rise in the number of patients with ESRD …

Live-donor kidney transplantation (LDKT) is the best treatment for eligible people with late-
stage kidney disease. Despite this, living kidney donation rates have declined in the United …

Despite its superior outcomes relative to chronic dialysis and deceased donor kidney
transplantation, live donor kidney transplantation (LDKT) is less likely to occur in minorities …

The presence of sex disparity in living donor kidney transplantation (LDKT) remains
controversial. To determine if women fall behind men in LDKT evaluation, we performed an …

The factors underlying the decline in living kidney donation in the United States since 2005
must be understood to inform strategies to ensure access to this option for future patients …

The supply of organs—particularly kidneys—donated by living and deceased donors falls
short of the number of patients added annually to transplant waiting lists in the United States …

Some living kidney donors (LKDs) incur costs associated with donation, although these
costs are not well characterized in the United States. We collected cost data in the 12 mo …

Because results from single-center (mostly kidney) donor studies demonstrate interpersonal
relationship and financial strains for some donors, we conducted a liver donor study …

Background Patient referral to a transplant facility, a prerequisite for dialysis-treated patients
to access kidney transplantation in Canada, is a subjective process that is not recorded in …